(Q40244962)

18 September 2017

1 reference

title

Anti-malarials in dermatology (English)

1 reference

18 September 2017

1 reference

Isaacson D

1

1 reference

PubMed ID

6752053

18 September 2017

Elgart M

series ordinal

2

1 reference

PubMed ID

6752053

18 September 2017

Turner ML

series ordinal

3

1 reference

18 September 2017

1 September 1982

1 reference

International Journal of Dermatology

18 September 2017

1 reference

18 September 2017

21

1 reference

18 September 2017

7

1 reference

18 September 2017

379-395

1 reference

Antimalarials in the management of discoid and systemic lupus erythematosus

18 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

PIGMENTATION FROM ANTIMALARIAL THERAPY. ITS POSSIBLE RELATIONSHIP TO THE OCULAR LESIONS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

STUDIES ON THE PHARMACOLOGY OF CHLOROQUINE. RECOMMENDATIONS FOR THE TREATMENT OF CHLOROQUINE RETINOPATHY.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

CHLOROQUINE. A REVIEW OF REACTIONS AND DERMATOLOGIC INDICATIONS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Effect of chloroquine on erythematous and carcinogenic response to ultraviolet light. Demonstrated in experimental animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Immunologic concepts of light reactions in lupus erythematosus and polymorphous light eruptions. I. The mechanism of action of hydroxychloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

The role of disulfide bonds in the acquisition of immunologic specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Synthetic models of deoxyribonucleic acid complexes with antimalarial compounds. I. Interaction of aminoquinoline with adenine and thymine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

The chemosuppression of chemotaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Chloroquine, quinine, procaine, quinidine, tricyclic antidepressants, and methylxanthines as prostaglandin agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

The Molecular Basis of the Action of Chloroquine in Porphyria Cutanea Tarda

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Antimalarial agents. Chloroquine, hydroxychloroquine, and quinacrine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Plaquenil in the treatment of discoid lupus erythematosus; a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Plaquenil sulfate in treatment of lupus erythematosus and light-sensitivity eruptions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Chloroquine diphosphate in treatment of discoid lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Intradermal administration of chloroquine for discoid lupus erythematosus and lichen sclerosus et atrophicus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Solar- vs heat-induced urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Solar urticaria treatment by inducing tolerance to artificial radiation and natural light

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Porphyria cutanea tarda. Clinical features and laboratory findings in 40 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Porphyria cutanea tarda treated with chloroquine phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Porphyria cutanea tarda. Remission following chloroquine administration without adverse effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

The treatment of sarcoidosis with chloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

THE RESPONSE OF HYPERCALCEMIA IN SARCOIDOSIS TO CHLOROQUINE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Disseminated granuloma annulare; report of a case treated with chloroquine phosphate (aralen).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Cutaneous cryptococcosis; presentation of a case and a review of previously reported cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Acrodermatitis chronica atrophicans; report of a case treated with chloroquine phosphate (aralen).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Visual Disturbances with Antimalarial Drugs, with Particular Reference to Chloroquine Keratopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Erythema annulare centrifugum due to hydroxychloroquine sulfate and chloroquine sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Lichenoid dermatitis due to chloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Exfoliative dermatitis as a complication of chloroquine (aralen) therapy in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

21 January 2018

Chloroquine psychosis?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

OCULAR LESIONS AFTER TREATMENT WITH CHLOROQUINE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Amodiaquine and hydroxychloroquine in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Chloroquine retinopathy. Evaluation by fluorescein fundus angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

Electroretinography in Patients with Connective Tissue Diseases Treated with Hydroxychloroquine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-4362.1982.TB03155.X

10.1111/J.1365-4362.1982.TB03155.X

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference

PubMed ID

6752053